Botulinum Toxin for Spasticity in Children With Cerebral Palsy: A Comprehensive Evaluation: Bjornson K et al.

Abstract
BACKGROUND — Spasticity is a prevalent disabling clinical symptom for children with cerebral palsy. Treatment of spasticity with botulinum toxin in children with cerebral palsy was first reported in 1993. Botulinum toxin provides a focal, controlled muscle weakness with reduction in spasticity. Interpretation of the literature is difficult due to the paucity of reliable measures of spasticity and challenges with measuring meaningful functional changes in children with disabilities …

Pediatrics . 2007 July ; 120(1): 49-58.

 
Kristie Bjornson, PhD, PT  a,
Ross Hays, MD  b,
Cathy Graubert, PT  a,
Robert Price, MS  b,
Francine Won, PT  a,
John F. McLaughlin, MD  c, and
Morty Cohen, RPh  a

 

Autoren-Details:
a   Children’s Hospital and Regional Medical Center, Seattle Washington
b   Rehabilitation Medicine, University of Washington, Seattle, Washington
c   Pediatrics, University of Washington, Seattle, Washington